A new three-drug immunotherapy combination significantly improves outcomes for relapsed follicular lymphoma, offering a chemotherapy-free treatment option DUBAI, RIYADH, DOHA,DECEMBER 22nd, 2025.Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading cancer treatment, education and research institutions, has released clinical trial resultsshowing that a new three-drug immunotherapy combination provides significantly better outcomes for people … Continue reading Memorial Sloan Kettering Cancer Center Announces Major Advance in Lymphoma Treatment at ASH 2025